Literature DB >> 15315811

Four-year language outcomes of children exposed to cocaine in utero.

Barbara A Lewis1, Lynn T Singer, Elizabeth J Short, Sonia Minnes, Robert Arendt, Paul Weishampel, Nancy Klein, Meeyoung O Min.   

Abstract

A large cohort of children exposed to cocaine in utero (n=189) were followed prospectively from birth to 4 years of age and compared to nonexposed children (n=185) on the Clinical Evaluation of Language Fundamentals-Preschool (CELF-P), a measure of receptive and expressive language abilities. Children exposed to cocaine in utero performed more poorly on the expressive and total language measures than nonexposed children after controlling for confounding variables, including prenatal exposure to alcohol, marijuana, and tobacco, as well as medical and sociodemographic variables. Children exposed to cocaine had more mild receptive language delays than nonexposed children and were less likely to have higher expressive abilities. Also, maternal factors such as language ability, performance IQ, race, and education correlated with child language abilities. Prenatal cigarette and marijuana exposure were related to deficits in specific language skills. Children placed in adoptive or foster care who were cocaine exposed demonstrated superior language skills compared to children exposed to cocaine who remained in biological relative or mother's care. These findings support a cocaine-specific effect on language skills in early childhood that may be modified with an enriched environment.

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 15315811     DOI: 10.1016/j.ntt.2004.06.007

Source DB:  PubMed          Journal:  Neurotoxicol Teratol        ISSN: 0892-0362            Impact factor:   3.763


  28 in total

1.  Cocaine causes deficits in radial migration and alters the distribution of glutamate and GABA neurons in the developing rat cerebral cortex.

Authors:  Chun-Ting Lee; Jia Chen; Lila T Worden; William J Freed
Journal:  Synapse       Date:  2011-01       Impact factor: 2.562

2.  Neuroimaging of prenatal drug exposure.

Authors:  Diana L Dow-Edwards; Helene Benveniste; Marylou Behnke; Emmalee S Bandstra; Lynn T Singer; Yasmin L Hurd; L R Stanford
Journal:  Neurotoxicol Teratol       Date:  2006 May-Jun       Impact factor: 3.763

3.  Neurobehavioral and Developmental Traiectories Associated with Level of Prenatal Cocaine Exposure.

Authors:  Claudia A Chiriboga; Louise Kuhn; Gail A Wasserman
Journal:  J Neurol Psychol       Date:  2014-11

Review 4.  Neuroimaging of children following prenatal drug exposure.

Authors:  Chris Derauf; Minal Kekatpure; Nurunisa Neyzi; Barry Lester; Barry Kosofsky
Journal:  Semin Cell Dev Biol       Date:  2009-03-13       Impact factor: 7.727

Review 5.  Prenatal substance abuse: short- and long-term effects on the exposed fetus.

Authors:  Marylou Behnke; Vincent C Smith
Journal:  Pediatrics       Date:  2013-02-25       Impact factor: 7.124

6.  Maternal cocaine use and caregiving status: group differences in caregiver and infant risk variables.

Authors:  Rina D Eiden; Audra Foote; Pamela Schuetze
Journal:  Addict Behav       Date:  2006-07-11       Impact factor: 3.913

7.  Prenatal drug exposure: effects on cognitive functioning at 5 years of age.

Authors:  Margaret B Pulsifer; Arlene M Butz; Megan O'Reilly Foran; Harolyn M E Belcher
Journal:  Clin Pediatr (Phila)       Date:  2007-08-31       Impact factor: 1.168

8.  Effects of prenatal cocaine exposure on infant reactivity and regulation.

Authors:  Rina D Eiden; Shannon McAuliffe; Lorig Kachadourian; Claire Coles; Craig Colder; Pamela Schuetze
Journal:  Neurotoxicol Teratol       Date:  2008-09-10       Impact factor: 3.763

Review 9.  Cocaine-induced neurodevelopmental deficits and underlying mechanisms.

Authors:  Melissa M Martin; Devon L Graham; Deirdre M McCarthy; Pradeep G Bhide; Gregg D Stanwood
Journal:  Birth Defects Res C Embryo Today       Date:  2016-06

10.  Profiles of Reactivity in Cocaine-Exposed Children.

Authors:  Pamela Schuetze; Danielle S Molnar; Rina D Eiden
Journal:  J Appl Dev Psychol       Date:  2012-10-11
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.